TY - JOUR
T1 - Acute polymyositis after donor lymphocyte infusion
AU - Lin, Peng Chan
AU - Hsiao, Liang Tsai
AU - Chen, Po Min
PY - 2005/2
Y1 - 2005/2
N2 - Polymyositis usually occurred along with other manifestations of chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT) had been reported. However, polymyositis with a sole manifestation of acute GVHD following donor lymphocyte infusion (DLI) is rare. We reported a 45-yr-old man of acute lymphoid leukemia post-allogeneic HSCT 6 months developed acute polymyositis after DLL He did not develop any symptoms, signs of acute or chronic GVHD following allogeneic HSCT, despite withdraw of immuosuppresive agents, cyclosporin A (CsA). As the DNA-STR of bone marrow analysis showed mixed chimerism, he received the DLI for remission on May 16, 2002. Acute polymyositis developed following DLI 22 d later. The clinical presentation of polymyositis is compatible with a manifestation of acute GVHD following DLI. It also responds to the treatment of steroid and CsA.
AB - Polymyositis usually occurred along with other manifestations of chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT) had been reported. However, polymyositis with a sole manifestation of acute GVHD following donor lymphocyte infusion (DLI) is rare. We reported a 45-yr-old man of acute lymphoid leukemia post-allogeneic HSCT 6 months developed acute polymyositis after DLL He did not develop any symptoms, signs of acute or chronic GVHD following allogeneic HSCT, despite withdraw of immuosuppresive agents, cyclosporin A (CsA). As the DNA-STR of bone marrow analysis showed mixed chimerism, he received the DLI for remission on May 16, 2002. Acute polymyositis developed following DLI 22 d later. The clinical presentation of polymyositis is compatible with a manifestation of acute GVHD following DLI. It also responds to the treatment of steroid and CsA.
UR - http://www.scopus.com/inward/record.url?scp=12944262291&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=12944262291&partnerID=8YFLogxK
U2 - 10.1111/j.1600-0609.2004.00344.x
DO - 10.1111/j.1600-0609.2004.00344.x
M3 - Article
C2 - 15654909
AN - SCOPUS:12944262291
SN - 0902-4441
VL - 74
SP - 166
EP - 168
JO - European Journal of Haematology
JF - European Journal of Haematology
IS - 2
ER -